3rd Quarter - Report

BIOTECHNOLOGY INNOVATION ORGANIZATION for BIOTECHNOLOGY INNOVATION ORGANIZATION

Firm
Client
Income
—
Expenses
$1,780,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

19 issue areas, each in the filer's own words, with who lobbied on it and where.

Animals ANI

Genetically Engineered (GE) Animals USDA APHIS Animal Care - Compliance with the Animal Welfare Act USDA APHIS Veterinary Service - Import and Export Issues Genetically Engineered (GE) Animals Cont... H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 USDA APHIS Biotechnology Regulatory Services - Regulatory Follow-up USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding FDA Final Guidance on Regulation of GE Animals FDA Approval of First Product from GE Animals Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production USDA APHIS Animal Care USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative - Research Funding H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 2007 Farm Bill Implementation Discussion with EU on Animal Cloning

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
BARBARA GLENN —
BILL A OLSON —
PAUL POTEET —

Contacted: U.S. Agency for International Development (USAID); Health & Human Services, Dept of (HHS); SENATE; Office of Science & Technology Policy (OSTP); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); U.S. Trade Representative (USTR); Office of Management & Budget (OMB); Small Business Administration (SBA); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Patent & Trademark Office (PTO); Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); Energy, Dept of; Commerce, Dept of (DOC); Food & Drug Administration (FDA); Environmental Protection Agency (EPA)

Bills named: S. 1406 (111th), H.R. 2997 (111th)

Medicare/Medicaid MMM

Medicaid Rebates H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 Outpatient Prospective Payment System CY2010 Proposed Regulations Payment Methodology for Separately Billable Drugs and Biologics

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
BRENT ALAN DELMONTE —
SANDRA DENNIS —
JEANNE HAGGERTY —
LAUREN PARKER NEFF —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition
LAUREL TODD —
ANNA KATHERINE WEINSTEIN New Intern for Sen. Leahy, Judiciary Com., 1994

Contacted: Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); Energy, Dept of; Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); U.S. Agency for International Development (USAID); State, Dept of (DOS); SENATE; Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); Small Business Administration (SBA); Congressional Budget Office (CBO); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); Agriculture, Dept of (USDA); Food & Drug Administration (FDA)

Bills named: H.R. 3200 (111th), S. 1679 (111th)

Pharmacy PHA

Medicaid Rebates H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 Comparative Effectiveness Program Initiatives Implementation of H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 2502: Comparative Effectiveness Research Act of 2009 H.R. 2824: Doctor-Patient Relationship and Research Protection Act S.1213: Patient-Centered Outcomes Research Act of 2009 H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 Outpatient Prospective Payment System CY2010 Proposed Regulations Payment Methodology for Separately Billable Drugs and Biologics Drug Safety and Review E-Pedigree and Anti-counterfeiting H.R. 2749: Food Safety Enhancement Act of 2009 H.R. 759: FDA Globalization Act of 2009 S. 882: Drugs and Device Accountability Act of 2009 The Food and Drug Administration Amendments Act of 2007 Implementation Risk Evaluation Mitigation Strategies Adverse Event Monitoring/Sentinel Network Advisory Committee System Critical Path FDA Regulatory Transparency Measurement Standards for Review and Approval of Biologics House Science Committee Hearing Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Department of Homeland Security Appropriations Act for FY 2010 S.1232: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 S.80: Pharmaceutical Market Access Act of 2009

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
TRICIA BROOKS —
EDWARD BUCKLEY —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
SANDRA DENNIS —
ANDREW EMMETT —
JEANNE HAGGERTY —
LAUREN PARKER NEFF Legislative Assistant, Rep. Deborah Pryce
DARYL PRITCHARD —
SARA RADCLIFFE —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —
LAUREL TODD —
ANNA KATHERINE WEINSTEIN New Intern for Sen. Leahy, Judiciary Com., 1994

Contacted: Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); U.S. Agency for International Development (USAID); U.S. Trade Representative (USTR); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Energy, Dept of; Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; SENATE; State, Dept of (DOS); Small Business Administration (SBA); Office of Science & Technology Policy (OSTP)

Bills named: H.R. 759 (111th), H.R. 2502 (111th), S. 1406 (111th), S. 1232 (111th), H.R. 2749 (111th), H.R. 2997 (111th), H.R. 3293 (111th), H.R. 1 (111th), H.R. 3200 (111th), S. 882 (111th), H.R. 2824 (111th), S. 80 (111th), S. 525 (111th), H.R. 1298 (111th), S. 1679 (111th), S. 1213 (111th)

Trade (domestic/foreign) TRD

Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement and Living Modified Organisms Act Revisions China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning India Bilateral Biotechnology Discussions Vietnam Biotechnology Regulations U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization Special 301 Submissions World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Department of Homeland Security Appropriations Act for FY 2010 S.1232: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 S.80: Pharmaceutical Market Access Act of 2009

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcommittee
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
ANDREW EMMETT —
LILA FEISEE —
BARBARA GLENN —
JEANNE HAGGERTY —
SARAH LUKIE —
BILL A OLSON —
PAUL POTEET —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —
ANNA KATHERINE WEINSTEIN New Intern for Sen. Leahy, Judiciary Com., 1994

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); SENATE; U.S. Agency for International Development (USAID); Patent & Trademark Office (PTO); State, Dept of (DOS); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); Office of Management & Budget (OMB); Energy, Dept of; Small Business Administration (SBA); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH)

Bills named: S. 1406 (111th), S. 1232 (111th), S. 80 (111th), S. 525 (111th), H.R. 2997 (111th), H.R. 3293 (111th), H.R. 1298 (111th)

Financial Institutions/Investments/Securities FIN

Listing Requirements on Exchanges SEC Proposed Rules Small Business Definition Amendment Investor Protection Act of 2009 House Discussion Draft SEC Rule 12b-2

LobbyistCovered position, as disclosed
BRENT ALAN DELMONTE —
ALAN EISENBERG —
SHELLY MUI-LIPNIK —
PAUL POTEET —
TOOSHAR SWAIN Legislative Correspondent, Senator Rick Santorum

Contacted: Commerce, Dept of (DOC); Securities & Exchange Commission (SEC); U.S. Agency for International Development (USAID); Small Business Administration (SBA); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Congressional Budget Office (CBO); Office of Management & Budget (OMB); State, Dept of (DOS); Energy, Dept of; Office of Science & Technology Policy (OSTP); Food & Drug Administration (FDA); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); SENATE; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES

Agriculture AGR

Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production Livestock Cloning/Product Labeling Cont... USDA APHIS Animal Care USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative - Research Funding H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of FY 2010 2007 Farm Bill Implementation Discussion with EU on Animal Cloning Foreign Agriculture Biotechnology Laws and Regulations U.S. Korea Free Trade Agreement and Living Modified Organisms Act Revisions China Biotechnology Bilateral Discussions Mexico Biotechnology Bilateral Discussions EU Biotechnology Bilateral Discussions Canada Biotechnology Bilateral Discussions Japan Biotechnology Bilateral Discussions Argentina Biotechnology Bilateral Discussions Brazil Biotechnology Bilateral Discussions APEC Agricultural Biotechnology Discussions Korean Biosafety Law Discussions with EU on Animal Cloning India Bilateral Biotechnology Discussions Vietnam Biotechnology Regulations U.S. Policy on International Science-Based Regulations USDA Export Strategy for Agricultural Biotechnology Products World Trade Organization on EU Biotech Approvals EU Biotechnology Negotiations Genetically Engineered (GE) Animals USDA APHIS Animal Care - Compliance with the Animal Welfare Act USDA APHIS Veterinary Service - Import and Export Issues H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of FY 2010 USDA APHIS Biotechnology Regulatory Services - Regulatory Follow-up USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding FDA Final Guidance on Regulation of GE Animals FDA Approval of First Product From GE Animals Cartagena Biosafety Protocol U.S. Government Positions/Activities/Communications at Biosafety Protocol Meetings USDA/APHIS Agricultural Biotechnology Regulations USDA Rulemaking on 7CFR 340 USDA Docket on Corn Amylase Petition (No. APHIS-2007-0016) Efficient Review of Biotech Products U.S. Policy on Sustainable Agriculture Standard American National Standards Institute Sustainable Agriculture Standards (ANSI) International Standards Organization Standard (ISO) Funding for the USDA H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 Biomass Crop Assistance Program (BCAP) BCAP Rulemaking and Environmental Impact Statement 2007 Farm Bill Implementation H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 U.S. Government Agriculture Research Funding H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Appropriations Act for FY 2010 Agriculture Federal Research Initiative for FY 2009 Global Food Security Initiative U.S. Government Strategy for Global Food Security Codex Alimentarius Commission Proposed Draft Guidelines for Risk Analysis of Foodborne Antimicrobial Resistance UN Climate Change Convention US Government Position on Ag-biotech and Intellectual Property Rights

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
TOM DILENGE —
LILA FEISEE —
BARBARA GLENN —
SARAH LUKIE —
BILL A OLSON —
PAUL POTEET —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Natl Institutes of Health (NIH); Energy, Dept of; Environmental Protection Agency (EPA); State, Dept of (DOS); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); U.S. Agency for International Development (USAID); U.S. Trade Representative (USTR); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Small Business Administration (SBA); SENATE; Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Office of Science & Technology Policy (OSTP)

Bills named: S. 1406 (111th), H.R. 2997 (111th)

Taxation/Internal Revenue Code TAX

Therapeutic Development Investment Tax Credit Senate Finance Committee's America's Healthy Future Act of 2009 Tax Legislation Bio-based Products Tax Credits Pharmaceutical Excise Tax Senate Finance Committee's America's Healthy Future Act of 2009 R&D Tax Credit Extension

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP, Subcommi
TRICIA BROOKS —
MATT CARR —
BRENT ALAN DELMONTE —
TOM DILENGE —
ALAN EISENBERG —
SHELLY MUI-LIPNIK —
PAUL POTEET —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition
TOOSHAR SWAIN Legislative Correspondent, Senator Rick Santorum
ANNA KATHERINE WEINSTEIN New Intern for Sen. Leahy, Judiciary Com., 1994

Contacted: Office of Science & Technology Policy (OSTP); SENATE; State, Dept of (DOS); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); U.S. Trade Representative (USTR); Commerce, Dept of (DOC); U.S. Agency for International Development (USAID); Health & Human Services, Dept of (HHS); Agriculture, Dept of (USDA); Energy, Dept of; Natl Institutes of Health (NIH); Small Business Administration (SBA); Congressional Budget Office (CBO); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC)

Copyright/Patent/Trademark CPT

Patent Reform H.R. 1260: The Patent Reform Act of 2009 S. 515. The Patent Reform Act of 2009 S. 610: The Patent Reform Act of 2009 World Trade Organization Special 301 Submissions Convention on Biological Diversity Patent Disclosure Requirements Bayh-Dole Act/Tech Transfer Gene Patenting HHS Secretary's Advisory Committee Report IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations PTO Administrative Reforms

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
TRICIA BROOKS —
EDWARD BUCKLEY —
BRENT ALAN DELMONTE —
TOM DILENGE —
ELIZABETH CARTIER ESHAM —
LILA FEISEE —
JEANNE HAGGERTY —
HANSJORG SAUER —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition
ANNA KATHERINE WEINSTEIN New Intern for Sen. Leahy, Judiciary Com., 1994

Contacted: Centers For Medicare and Medicaid Services (CMS); U.S. Agency for International Development (USAID); Energy, Dept of; Securities & Exchange Commission (SEC); Food & Drug Administration (FDA); Congressional Budget Office (CBO); U.S. Trade Representative (USTR); Natl Institutes of Health (NIH); State, Dept of (DOS); Commerce, Dept of (DOC); Small Business Administration (SBA); SENATE; Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Patent & Trademark Office (PTO); Agriculture, Dept of (USDA)

Bills named: S. 515 (111th), H.R. 1260 (111th), S. 610 (111th)

Health Issues HCR

Healthcare Reform H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 Health Care Reform Cont... Comparative Effectiveness Research Program Initiatives Hospital Acquired Infections Policy In Vitro Diagnostics Regulatory Oversight Vaccine Access/Financing Follow-on Biologics Reporting of Physician Payments Expansion of 340B Drug Pricing Program Medicaid Rebates S.1213: Patient-Centered Outcomes Research Act of 2009 H.R. 2502: Comparative Effectiveness and Research Protection Act H.R. 2824 Doctor-Patient Relationship and Research Protection Act Pharmaceutical Excise Tax Funding for the Food and Drug Administration H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Stem Cell Research Medicaid Rebates H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 Follow-on Biologics H.R. 1427: Promoting Innovation and Access to Life-Saving Medicines Act H.R. 1548: Pathway for Biosimilars Act of 2009 S. 726: Promoting Innovation and Access to Life-Saving Medicine Act FTC Report on Follow-on Biologics Marketplace H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 House Judiciary Committee Hearing on Patent Issues Drug Safety and Review E-Pedigree and Anti-counterfeiting H.R. 2749: Food Safety Enhancement Act of 2009 H.R. 759: FDA Globalization Act of 2009 S. 882: Drugs and Device Accountability Act of 2009 The Food and Drug Administration Amendments Act of 2007 Implementation Risk Evaluation Mitigation Strategies Adverse Event Monitoring/Sentinel Network Advisory Committee System Critical Path FDA Regulatory Transparency Measurement Standards for Review and Approval of Biologics House Science Committee Hearing Funding for Biomedical Advanced Research & Development Authority (BARDA) H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 In Vitro Diagnostics Regulatory Oversight H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 Comparative Effectiveness Program Initiatives Implementation of H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 2502: Comparative Effectiveness Research Act of 2009 H.R. 2824: Doctor-Patient Relationship and Research Protection Act S.1213: Patient-Centered Outcomes Research Act of 2009 H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 Funding for National Institutes of Health H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Bioterrorism and Emergency Preparedness H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Pandemic Influenza Preparedness H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Reporting of Physician Payments S. 301: Physician Payments Sunshine Act of 2009 H.R. 3200: America's Affordable Health Choices Act Senate Finance Committee's America's Healthy Future Act of 2009 Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Department of Homeland Security Appropriations Act for FY 2010 S.1232: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 S.80: Pharmaceutical Market Access Act of 2009 Vaccine Access/Financing H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 FDA Regulatory Processes for First-Time Filers Expansion of 340B Drug Pricing Program H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 S.1239: 340B Program Improvement and Integrity Act of 2009 Outpatient Prospective Payment System CY2010 Proposed Regulations Payment Methodology for Separately Billable Drugs and Biologics

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
TRICIA BROOKS —
EDWARD BUCKLEY —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
SANDRA DENNIS —
TOM DILENGE —
ANDREW EMMETT —
JEANNE HAGGERTY —
KATHERINE MCCARTHY —
SHELLY MUI-LIPNIK —
LAUREN PARKER NEFF Legislative Assistant, Rep. Deborah Pryce
DARYL PRITCHARD —
SARA RADCLIFFE —
HANSJORG SAUER —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —
LAUREL TODD —
ANNA KATHERINE WEINSTEIN New Intern for Sen. Leahy, Judiciary Com., 1994

Contacted: U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Small Business Administration (SBA); Patent & Trademark Office (PTO); HOUSE OF REPRESENTATIVES; U.S. Agency for International Development (USAID); Securities & Exchange Commission (SEC); Office of Science & Technology Policy (OSTP); SENATE; Commerce, Dept of (DOC); Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); Energy, Dept of; Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); State, Dept of (DOS)

Bills named: S. 80 (111th), S. 726 (111th), S. 301 (111th), H.R. 1 (111th), H.R. 3293 (111th), H.R. 1427 (111th), H.R. 2824 (111th), H.R. 3200 (111th), S. 1213 (111th), S. 1679 (111th), S. 882 (111th), S. 1239 (111th), H.R. 2997 (111th), S. 1406 (111th), H.R. 2749 (111th), H.R. 759 (111th), S. 1232 (111th), S. 525 (111th), H.R. 1548 (111th), H.R. 1298 (111th), H.R. 2502 (111th)

Fuel/Gas/Oil FUE

Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MATT CARR —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
TOM DILENGE —
AMY EHLERS —
BRENT ERICKSON —
LILA FEISEE —
BILL A OLSON —
PAUL POTEET —

Contacted: Office of Science & Technology Policy (OSTP); Office of Management & Budget (OMB); Securities & Exchange Commission (SEC); Agriculture, Dept of (USDA); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Congressional Budget Office (CBO); SENATE; Food & Drug Administration (FDA); U.S. Agency for International Development (USAID); Patent & Trademark Office (PTO); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); Energy, Dept of; Health & Human Services, Dept of (HHS); U.S. Trade Representative (USTR); State, Dept of (DOS); Small Business Administration (SBA); Commerce, Dept of (DOC)

Bills named: H.R. 3183 (111th), S. 1436 (111th), H.R. 2996 (111th), S. 1406 (111th), S. 1 (111th), S. 1250 (111th), H.R. 2454 (111th), H.R. 2997 (111th), S. 1013 (111th)

Small Business SMB

Small Business Innovation and Research (SBIR) Program Reauthorization H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009 SBA Grant Proposal for Early Stage Investment SBA Early Stage Investment Act of 2009 Discussion Draft FDA Regulatory Processes for First-Time Filers Listing Requirements on Exchanges SEC Proposed Rules Therapeutic Development Investment Tax Credit Tax Legislation Senate Finance Committee's America's Healthy Future Act of 2009 Small Business Definition Amendment Investor Protection Act of 2009 House Discussion Draft SEC Rule 12b-2

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
TRICIA BROOKS —
BRENT ALAN DELMONTE —
TOM DILENGE —
ALAN EISENBERG —
ELIZABETH CARTIER ESHAM —
SHELLY MUI-LIPNIK —
PAUL POTEET —
TOOSHAR SWAIN Legislative Correspondent, Senator Rick Santorum
ANNA KATHERINE WEINSTEIN New Intern for Sen. Leahy, Judiciary Com., 1994

Contacted: Office of Management & Budget (OMB); State, Dept of (DOS); Natl Institutes of Health (NIH); Office of Science & Technology Policy (OSTP); Environmental Protection Agency (EPA); U.S. Agency for International Development (USAID); Centers For Medicare and Medicaid Services (CMS); Agriculture, Dept of (USDA); Commerce, Dept of (DOC); Energy, Dept of; U.S. Trade Representative (USTR); Securities & Exchange Commission (SEC); Congressional Budget Office (CBO); Patent & Trademark Office (PTO); Small Business Administration (SBA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Food & Drug Administration (FDA)

Bills named: H.R. 2965 (111th), S. 1233 (111th)

Budget/Appropriations BUD

H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Funding for the Food and Drug Administration (Human Drug Review, Biologics, Food Safety, Critical Path, Reagan-Udall Foundation, Center for Veterinary Medicine) H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Cont... Funding for the USDA: Biotechnology Regulatory Service (APHIS), Animal Care & Veterinary Services (APHIS), Trade Activities (Office of the Secretary & Food Safety Inspection Service), Agriculture Research Service, Biofuels (Rural Development)) Genetically Engineered (GE) Animals Livestock Cloning/Product Labeling Funding for Biofuels and Bio-based Products Drug Importation H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Funding for National Institutes of Health Funding for Bioterrorism and Emergency Preparedness Funding for Pandemic Influenza Preparedness Funding for Biomedical Advanced Research and Development Authority (BARDA) Drug Importation H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 Funding for Biofuels and Bio-based Products H.R. 3081/S.1434: Department of State, Foreign Operations and Related Programs Appropriations Act for FY 2010 Funding for Biotechnology Research and Development Programs at the Agency for International Development H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Funding for Biofuels at the U.S. Forest Service Funding for Bio-based Products Climate Change/Indirect Land Use Department of Homeland Security Appropriations Act for FY 2010 Drug Importation

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommi
TRICIA BROOKS —
MATT CARR —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
AMY EHLERS —
ANDREW EMMETT —
BRENT ERICKSON —
BARBARA GLENN —
PAUL POTEET —
DARYL PRITCHARD —
SARA RADCLIFFE —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —

Contacted: State, Dept of (DOS); Agriculture, Dept of (USDA); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES; Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); SENATE; Health & Human Services, Dept of (HHS); Small Business Administration (SBA); Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Energy, Dept of; Office of Management & Budget (OMB); U.S. Agency for International Development (USAID); Congressional Budget Office (CBO); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP)

Bills named: H.R. 2997 (111th), H.R. 2996 (111th), S. 1436 (111th), S. 1434 (111th), H.R. 3293 (111th), S. 1406 (111th), H.R. 3081 (111th), H.R. 3183 (111th)

Consumer Issues/Safety/Products CSP

Genetically Engineered (GE) Animals USDA APHIS Animal Care - Compliance with the Animal Welfare Act USDA APHIS Veterinary Service - Import and Export Issues Genetically Engineered (GE) Animals Cont... H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 USDA APHIS Biotechnology Regulatory Services - Regulatory Follow-up USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding FDA Final Guidance on Regulation of GE Animals FDA Approval of First Product from GE Animals Funding for the Food and Drug Administration H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related agencies Appropriations Act for FY 2010 Reporting of Physician Payments S.310: Physician Payments Sunshine Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 H.R. 3200: America's Affordable Health Choices Act Drug Safety and Review E-Pedigree and Anti-counterfeiting H.R. 2749: Food Safety Enhancement Act of 2009 H.R. 759: FDA Globalization Act of 2009 S. 882: Drugs and Device Accountability Act of 2009 The Food and Drug Administration Amendments Act of 2007 Implementation Risk Evaluation Mitigation Strategies Adverse Event Monitoring/Sentinel Network Advisory Committee System Critical Path FDA Regulatory Transparency Measurement Standards for Review and Approval of Biologics House Science Committee Hearing Drug Importation S.525: Pharmaceutical Market Access and Drug Safety Act of 2009 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 3293: Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 Department of Homeland Security Appropriations Act for FY 2010 S.1232: Pharmaceutical Market Access Act of 2009 H.R. 1298: Pharmaceutical Market Access and Drug Safety Act of 2009 S.80: Pharmaceutical Market Access Act of 2009 Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production USDA APHIS Animal Care USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative - Research Funding H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 2007 Farm Bill Implementation Discussion with EU on Animal Cloning USDA/APHIS Agricultural Biotechnology Regulations USDA Rulemaking on 7CFR 340 USDA Docket on Corn Amylase Petition (No. APHIS-2007-0016) Efficient Review of Biotech Products

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
SANDRA DENNIS —
ANDREW EMMETT —
BARBARA GLENN —
JEANNE HAGGERTY —
PAUL POTEET —
SARA RADCLIFFE —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —
ANNA KATHERINE WEINSTEIN New Intern for Sen. Leahy, Judiciary Com., 1994

Contacted: Office of Science & Technology Policy (OSTP); Energy, Dept of; Health & Human Services, Dept of (HHS); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Congressional Budget Office (CBO); Office of Management & Budget (OMB); U.S. Agency for International Development (USAID); Small Business Administration (SBA); SENATE; Environmental Protection Agency (EPA); Natl Institutes of Health (NIH); Food & Drug Administration (FDA); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Securities & Exchange Commission (SEC); State, Dept of (DOS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2749 (111th), H.R. 759 (111th), S. 310 (111th), H.R. 1298 (111th), S. 525 (111th), S. 882 (111th), S. 1406 (111th), S. 80 (111th), H.R. 3200 (111th), S. 1232 (111th), H.R. 3293 (111th), H.R. 2997 (111th)

Energy/Nuclear ENG

Renewable Fuels Standard EPA Rulemaking on Life-cycle Greenhouse Gas Emissions Requirements Implementation of Energy Independence and Security Act of 2007 Algae-based Renewable Fuel/Carbon Capture and Conversion S.1013: Department of Energy Carbon Capture and Sequestration Program Amendments Act of 2009 S.1250: Algae-based Renewable Fuel Promotion Act of 2009 Biofuels H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 Loan Guarantees and Grants under S.1: American Recovery and Reinvestment Act Bio-based Products H.R. 3183/S.1436: Energy and Water Development and Related Agencies Appropriations Act for FY 2010 H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for FY 2010 H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Biopreferred Program Implementation under 2007 Farm Bill Tax Credit Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MATT CARR —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
TOM DILENGE —
AMY EHLERS —
BRENT ERICKSON —
LILA FEISEE —
BILL A OLSON —

Contacted: Energy, Dept of; Food & Drug Administration (FDA); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); Securities & Exchange Commission (SEC); Environmental Protection Agency (EPA); State, Dept of (DOS); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Congressional Budget Office (CBO); Small Business Administration (SBA); SENATE; Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); U.S. Agency for International Development (USAID)

Bills named: H.R. 2997 (111th), S. 1 (111th), H.R. 3183 (111th), H.R. 2454 (111th), S. 1013 (111th), S. 1406 (111th), H.R. 2996 (111th), S. 1436 (111th), S. 1250 (111th)

Food Industry (safety, labeling, etc.) FOO

Genetically Engineered (GE) Animals USDA APHIS Animal Care - Compliance with the Animal Welfare Act USDA APHIS Veterinary Service - Import and Export Issues Genetically Engineered (GE) Animals Cont... H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act of FY 2010 USDA APHIS Biotechnology Regulatory Services - Regulatory Follow-up USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative, Research Funding FDA Final Guidance on Regulation of GE Animals FDA Approval of First Product From GE Animals Livestock Cloning/Product Labeling FDA Risk Assessment on Cloning USDA Economic Research Service Report on Impact of Cloning on US Agriculture and Food Production USDA APHIS Animal Care USDA, Cooperative State Research Education and Extension Service, National Institute of Food & Agriculture, Agriculture Food Research Initiative - Research Funding H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 2007 Farm Bill Implementation Discussion with EU on Animal Cloning Food Safety Funding H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Global Food Security Initiative U.S. Government Strategy for Global Food Security Codex Alimentarius Commission Proposed Draft Guidelines for Risk Analysis of Foodborne Antimicrobial Resistance

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
BARBARA GLENN —
BILL A OLSON —

Contacted: Patent & Trademark Office (PTO); Energy, Dept of; Office of Science & Technology Policy (OSTP); Congressional Budget Office (CBO); Centers For Medicare and Medicaid Services (CMS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Environmental Protection Agency (EPA); U.S. Agency for International Development (USAID); Securities & Exchange Commission (SEC); U.S. Trade Representative (USTR); Agriculture, Dept of (USDA); Natl Institutes of Health (NIH); State, Dept of (DOS); Small Business Administration (SBA); Office of Management & Budget (OMB); Commerce, Dept of (DOC); SENATE

Bills named: S. 1406 (111th), H.R. 2997 (111th)

Homeland Security HOM

Funding for Pandemic Influenza Preparedness H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Biomedical Advanced Research & Development Authority (BARDA) H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Bioterrorism and Emergency Preparedness H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010

LobbyistCovered position, as disclosed
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
SARA RADCLIFFE —
JOHN MACK TAYLOR —

Contacted: Environmental Protection Agency (EPA); Securities & Exchange Commission (SEC); Centers For Medicare and Medicaid Services (CMS); Small Business Administration (SBA); U.S. Agency for International Development (USAID); HOUSE OF REPRESENTATIVES; Natl Institutes of Health (NIH); U.S. Trade Representative (USTR); Office of Science & Technology Policy (OSTP); SENATE; Commerce, Dept of (DOC); Energy, Dept of; State, Dept of (DOS); Agriculture, Dept of (USDA); Patent & Trademark Office (PTO); Office of Management & Budget (OMB); Congressional Budget Office (CBO); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS)

Bills named: H.R. 3293 (111th)

Medical/Disease Research/Clinical Labs MED

Funding for Bioterrorism and Emergency Preparedness H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for National Institutes of Health H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for Biomedical Advanced Research & Development Authority (BARDA) H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 Funding for the Food and Drug Administration H.R. 2997/S.1406: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act for FY 2010 Funding for Pandemic Influenza Preparedness H.R. 3293: Departments of Labor, Health and Human Services and Education, and Related Agencies Appropriations Act for FY 2010 In Vitro Diagnostics Regulatory Oversight H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009 Stem Cell Research Comparative Effectiveness Program Initiatives Implementation of H.R. 1. and S.Amdt. 570: American Recovery and Reinvestment Act of 2009 H.R. 2502: Comparative Effectiveness Research Act of 2009 H.R. 2824: Doctor-Patient Relationship and Research Protection Act S.1213: Patient-Centered Outcomes Research Act of 2009 H.R. 3200: America's Affordable Health Choices Act S.1679: America's Affordable Health Choices Act of 2009 Senate Finance Committee's America's Healthy Future Act of 2009

LobbyistCovered position, as disclosed
MELISSA BOWIE Chief Health Counsel, Senate HELP Subcommittee
TRICIA BROOKS —
EDWARD BUCKLEY —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
ANDREW EMMETT —
JEANNE HAGGERTY —
LAUREN PARKER NEFF Legislative Assistant, Rep. Deborah Pryce
DARYL PRITCHARD —
SARA RADCLIFFE —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition
JOHN MACK TAYLOR —
LAUREL TODD —

Contacted: SENATE; Congressional Budget Office (CBO); Agriculture, Dept of (USDA); U.S. Trade Representative (USTR); U.S. Agency for International Development (USAID); Office of Management & Budget (OMB); Small Business Administration (SBA); State, Dept of (DOS); Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Energy, Dept of; Natl Institutes of Health (NIH); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Commerce, Dept of (DOC); Securities & Exchange Commission (SEC); Patent & Trademark Office (PTO); Environmental Protection Agency (EPA)

Bills named: S. 1213 (111th), H.R. 2502 (111th), H.R. 3293 (111th), S. 1406 (111th), H.R. 1 (111th), H.R. 3200 (111th), S. 1679 (111th), H.R. 2997 (111th), H.R. 2824 (111th)

Science/Technology SCI

Small Business Innovation and Research (SBIR) Program Reauthorization H.R. 2965/S.1233: Enhancing Small Business Research and Innovation Act of 2009 Biotech Innovation/R&D Initiatives Research & Development Tax Credit Extension Measurements Standards for Review and Approval of Biologics House Science Committee Hearing Stem Cell Research

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
TRICIA BROOKS —
BRENT ALAN DELMONTE —
ALAN EISENBERG —
BRENT ERICKSON —
ELIZABETH CARTIER ESHAM —
PAUL POTEET —
SARA RADCLIFFE —
MATTHEW SCHUMAKER Executive Director, New Democrat Coalition

Contacted: Patent & Trademark Office (PTO); Environmental Protection Agency (EPA); Energy, Dept of; U.S. Agency for International Development (USAID); Agriculture, Dept of (USDA); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Small Business Administration (SBA); Congressional Budget Office (CBO); U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); State, Dept of (DOS); Office of Science & Technology Policy (OSTP); Centers For Medicare and Medicaid Services (CMS); Securities & Exchange Commission (SEC); SENATE; Commerce, Dept of (DOC); Natl Institutes of Health (NIH)

Bills named: S. 1233 (111th), H.R. 2965 (111th)

Clean Air and Water (quality) CAW

Climate Change Benefits of Biofuels and Bio-based Products H.R. 2454: American Clean Energy and Security Act of 2009 Clean Energy Jobs and American Power Act of 2009 Senate Discussion Draft U.S. Government Position for U.N. Convention on Climate Change Negotiations IP Rights for Environmental Technologies U.S. Government Position for U.N. Convention on Climate Change Negotiations Climate Change/Indirect Land Use H.R. 2996: Department of the Interior, Environment, and Related Agencies Appropriations Act for 2010

LobbyistCovered position, as disclosed
SHARON BOMER LAURITSEN —
MATT CARR —
PATRICK BRAERTON CARROLL Legislative Assistant, Rep. Ray LaHood
BRENT ALAN DELMONTE —
TOM DILENGE —
AMY EHLERS —
BRENT ERICKSON —
LILA FEISEE —
BILL A OLSON —

Contacted: U.S. Trade Representative (USTR); Patent & Trademark Office (PTO); U.S. Agency for International Development (USAID); State, Dept of (DOS); Natl Institutes of Health (NIH); Environmental Protection Agency (EPA); SENATE; Centers For Medicare and Medicaid Services (CMS); Energy, Dept of; Agriculture, Dept of (USDA); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Office of Science & Technology Policy (OSTP); Securities & Exchange Commission (SEC); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); Office of Management & Budget (OMB); Small Business Administration (SBA)

Bills named: H.R. 2454 (111th), H.R. 2996 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.